Dr. Suma B V

• Interest: Computational studies, Synthetic Chemistry, Analytical method development and validation by spectrophotometric and chromatographic techniques.
• Expertise: Computational studies, Synthetic Chemistry, Analytical method development and validation by spectrophotometric and chromatographic techniques

• Pretisha Flora Cutinho, C. H. S. Venkataramana, B. V. Suma, In Silico Hit Identification, Drug Repurposing, Pharmacokinetic and Toxicity Prediction of c-Met Kinase Inhibitors for Cancer Therapy, DOI: https://doi.org/10.1039/9781839160783-00054, Published: 19 Nov 2019, Special Collection: 2019 ebook collection

• Received II prize for oral presentation on Exploring Tetrahydro Pyrimidines For Tuberculosis Treatment: Molecular Docking And ADMET Insights at SPER 14th Annual International Conference & Exhibition (SPER 2025), NITTE, NGSM Institute of Pharmaceutical Sciences (Deemed to be University), Mangalore, Karnataka, India, held on January 24–25, 2025.
• The Innovative Global Scientific Researchers Educationalist-Professionals & Journalist Awards & Fellowship Honors Convocation 2020–21 awarded by the International Conference on Dissemination of Innovative Scientific Research Strategies (ISRS 2020–21).
• “Women of Science Award”: Outstanding Professor of RUAS by Ramaiah University of Applied Sciences for the year 2020 on National Science Day, 28th February 2020.
• Adarsh Vidya Saraswati Rashtriya Puraskar awarded by Global Management Council and Glacier Journal of Scientific Research for the academic year 2018.
• Certificate for Excellence in Reviewing by the Journal of Advances in Medicinal and Pharmaceutical Sciences for the year 2017.
• Award for Excellence for Women (2013) by Gokula Education Foundation (Medical).
• Best Teacher Performer 2012 – Q.A. audit by students & peers evaluation; Appreciation by the Chief Executive, Gokula Education Foundation (Medical).

Achievements:

Editor:

• Editorial Board Member of World Journal of Pharmaceutical Sciences
• Academic Editor of ‘Journal of Complementary and Alternative Medical Research’
• Editorial Board Member of IJOCPT: International Journal of Chemistry, Pharmacy and Technology

MANUSCRIPT REVIEWER:

• Drug Development and Industrial Pharmacy
• Journal of Pharmaceutical Research International
• International Journal of Plant and Soil Science
• Informatics in Medicine Unlocked
• Annual Research and Review in Biology
• British Journal of Medicine and Medical Research
• Advance in Research
• International Research Journal of Pure and Applied Chemistry
• Journal of Advances in Medicinal and Pharmaceutical Sciences

National Journal Papers

• Suma B.V., Joel MonichenThachemperil and Venkataramana C.H.S. Spectrophotometric Method (Jan 2018) Development and Validation of Azithromycin in Tablet Formulation Journal of Dental & Oro-facial Research, Vol. 14 Issue 01,23-27 Corresponding Author

International Journal Papers

• SriSatya Medicharla, Tanya Maheshwari, Suma B V – In Silica studies of Designed Thiadiazole Derivatives as Retinoic Acid Receptor Alpha (RaR-α) Inhibitors for Potential Contraceptive Application, Journal of Biomolecular Structure and Dynamics, Corresponding Author
• Sherya Shet and Suma B. V. (2024) – Synthesis And Evaluation Of A Coumarin Schiff-Base For In Vitro Antibacterial Activity Against Staphylococcus Aureus, International Journal of Pharmacy and Pharmaceutical Sciences, December, Volume: 20, Issue: 12, Page No. 26–30 DOI:10.22159/ijpps.2024v16i12.52430, Corresponding Author
• Apeksha K. Hegde and Suma B. V. (2024) – Tetrahydropyrimidines Via The Biginelli Reaction: Synthetic Strategies And Biological Activities, World Journal of Pharmaceutical Research, August, Volume: 13, Issue: 16, Page No. 190–210 DOI:10.20959/wjpr202416-33473, Corresponding Author
• Sherya Shet and Suma B. V. (2024) – Synthesis And Evaluation Of A Coumarin Schiff-Base For In Vitro Anti-Inflammatory Activity Targeting Human Cox-2, World Journal Of Pharmacy And Pharmaceutical Sciences, August, Volume: 13, Issue: 9, Page No. 865–871, DOI:10.20959/wjpps20249-28166, Corresponding Author
• Sherya Shet and Suma B. V. (2024) – Coumarins: Paving the Future Path Towards Antibacterial and Anti-inflammatory Therapies, International Journal of Science and Research (IJSR), October, Volume 13, Issue:10, Page No.567–576, DOI: https://dx.doi.org/10.21275/SR241004171133, Corresponding Author
• Jabeen, Suma B V (2024) – Simultaneous determination of Cefepime and Tazobactam by using Hyphenated Liquid Chromatography (UPLC-MS/MS), Research J. Pharm. and Tech, Volume 17, Issue 1, PP-67–73, DOI:10.52711/0974-360X.2024.00011, Scopus [Q2], Co-Authored
• Jabeen, Suma BV. (2023) – Stability indicating UPLC-MS/MS method for quantification and identification of cefepime and its degradants in API, J Appl Pharm Sci, Vol. 13(05), pp 199–207, May 2023, https://doi.org/10.7324/JAPS.2023.118104, Scopus [Q2], Co-Authored
• Jabeen and Suma B.V., (2022) – Newly Validated Stability-Indicating Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Method for the Estimation of Ceftaroline Fosamil by Using a Quadrupole Mass Detector, J Appl Pharm Sci, 12(06), 215–223, http://dx.doi.org/10.7324/JAPS.2022.120621, Scopus [Q2], Co-Authored
• Jabeen, Suma B.V., (2022) – A Critical Review of Analytical Methods for Determination of Ceftaroline Fosamil, J Res Med Dent Sci, 10(8): 91–95, Publons, Co-Authored
• Burhanuddin Madriwala, Suma B. V., Judy Jays (2022) – Molecular docking study of hentriacontane for anticancer and antitubercular activity, International Journal of Chemistry Research, 6(4), pp 1–4, Google Scholar, Citation factor 1.48, Co-Authored
• Aiswariya, Suma B.V, Medicharla Sri Satya (2022) – Molecular Docking and ADMET Studies of Benzotriazole Derivatives Tethered with Isoniazid for Antifungal Activity, International Journal of Current Pharmaceutical Research, Vol 14, Issue 4, Page No. 78–80, Scopus Indexed, Co-Authored
• Medicharla Sri Satya, Suma B.V, Aiswariya (2022) – Molecular Docking and ADMET Studies of Ethanone, 1-(2-Hydroxy-5-Methyl Phenyl) for Anti-Microbial Properties, Int J Pharm Pharm Sci, Vol 14, Issue 6, June 2022, pp. 24–27, Scopus Indexed, Co-Authored
• Suma B V, Harish Kumar D, Nuthan S, Anusha M, Kusuma S, Ranjith Reddy J P, Hima Susan – Evaluation studies of sodium and potassium ions in canned and fresh fruit juices by flame photometry, Life Science Edge, September 2019, Vol. 5, Issue 1, 58–64, Corresponding Author
• B.V. Suma, Deveswaran R. Premnath Shenoy – A new high-performance thin layer chromatographic method development and validation of dapagliflozin in bulk and tablet dosage form, International Journal of Pharmacy and Pharmaceutical Sciences, Vol 11, Issue 8, 2019, 58–63, DOI: http://dx.doi.org/10.22159/ijpps.2019v11i8.34339, Corresponding Author, Scopus Indexed
• B. V. Suma and R. Deveswaran – An overview on Analytical Methods for Dapagliflozin – An Antidiabetic drug, IJPSR, 2019, Vol. 10(6): 2688–2692, Corresponding Author, Scopus Indexed
• Chimatapu H.S. Venkataramana, Suma. B. Venkatappa, Joel M. Thachemperi – Extractive spectrophotometric method development and validation of cefepime hydrochloride in tablet formulation, World Journal of Pharmacy and Pharmaceutical Sciences, Vol 7, Issue 7, 2018, pp. 688–696, Corresponding Author, Scopus Indexed
• Harish Kumar D.R, Suma B.V, Abhilash B. Hiremath, Vijaybhanu P, C.H.S. Venkataramana – HPTLC method development and validation of cefepime and tazobactam in combined parenteral dosage form, Int J Pharma Bio Sci, 2018 April; 9(2): (P) 246–254, Web of Science, Corresponding Author
• Suma B.V., Joel Monichen Thachemperil, Venkataramana C.H.S – Spectrophotometric Method Development and Validation of Azithromycin in Tablet Formulation, Journal of Dental & Oro-facial Research, Vol. 14, Issue 01, Jan. 2018, Corresponding Author
• Suma B.V, Kannan K, Madhavan V, Chandini R Nayar – Spectrophotometric estimation of ambroxol hydrochloride in bulk and tablet formulation, World Journal of Pharmacy and Pharmaceutical Sciences, 2014, 3(2), 2090–2097, Corresponding Author, Scopus Indexed
• B.V. Suma, K. Kannan, V. Madhavan, Chandini R. Nayar – High Performance Thin Layer Chromatographic Estimation of Atorvastatin Calcium and Aspirin in Capsule Dosage Form, International Journal of Pharmaceutical Sciences Review and Research, Volume 19, Issue 1, Mar–Apr 2013; pp 92–95, Corresponding Author, Scopus Indexed
• B.V. Suma, S. Vijayalakshmi, V. Madhavan, Anita Murali – Synthesis and pharmacological activity of some novel 1,3,4-thiadiazole derivatives, Medicinal Chemistry & Drug Discovery, 2013, 4(2), 100–107, Corresponding Author
• B.V. Suma, K. Kannan, V. Madhavan, Chandini R. Nayar – Simultaneous Estimation and Validation of Atorvastatin Calcium and Aspirin in Combined Capsule Dosage Form by RP HPLC Method, E-Journal of Chemistry, 2012, 9(3), pp. 1449–1456, Corresponding Author, Web of Science
• B.V. Suma, Surendra Kumar, C. H. S. Venkataramana, Judy Jays, V. Madhavan – Synthesis and Biological Evaluation of 2-(1h-Benzotriazol-1-Yl) Acetohydrazide Containing Isatin Derivatives, Am. J. PharmTech Res. 2012; 2(3), pp. 559–567, Corresponding Author, Google Scholar
• B.V. Suma, N.N. Natesh, C.H.S. Venkataramana, Judy Jays, V. Madhavan – Synthesis and antibacterial of some new 1,2,3 benzotriazoles derivatives containing pyrazolidinedione moieties, International Journal of Pharmacy and Pharmaceutical Sciences, Vol 4, Issue 1, 2012, pp.169–173, Corresponding Author, Google Scholar
• B.V. Suma, N.N. Natesh, G.R. Saraswathy, V. Madhavan – Synthesis and pharmacological evaluation of some novel benzotriazoles derivatives containing pyrazolidinedione moieties, International Journal of Pharmacy and Technology, 3(2), 2012, 100–106, Corresponding Author, Google Scholar
• Suma B.V., Kannan K, Madhavan V, Chandini R Nayar – Simultaneous estimation and validation of atorvastatin calcium and nicotinic acid in combined tablet dosage form by RP HPLC method, International Journal of Pharmacy and Pharmaceutical Sciences, Vol 4, Issue 1, 2012, pp. 369–373, Corresponding Author, Google Scholar
• Suma B.V., Kannan K, Madhavan V, Chandini R Nayar – HPTLC Method for determination of Terbinafine in the Bulk drug and Tablet dosage form, International Journal of ChemTech Research, Vol. 3, No. 2, pp. 742–748, April–June 2011, Corresponding Author
• B. V. Suma, N. N. Natesh, V. Madhavan – Benzotriazole in medicinal chemistry: An overview, J. Chem. Pharm. Res., 2011, 3(6): 375–381, Corresponding Author, SCImage journal rank: 0.14 (2019), Q3 journal
• Ankit K. Rochani, B.V. Suma, C.H.S. Venkataramana, Judy Jays, V. Madhavan – Drug design and In-Silico Hepatotoxicity studies of Synthesized Novel 4-Quinolone containing Pyrazolidinedione derivatives, International Journal of Chem Tech Research, July–Sept 2011, Vol. 3, No. 3, pp. 1668–1680, Corresponding Author, Elsevier Indexed
• Suma B.V., Kannan K, Madhavan V, Chandini R Nayar – High performance thin layer chromatographic estimation of atorvastatin calcium and nicotinic acid in tablet formulation, International Journal of Pharmaceutical Sciences Review and Research, Volume 10, Issue 1, Sept–Oct 2011, Article-014, Corresponding Author
• Judy Jays, Amit Kumar, C.H.S. Venketaramana, B.V. Suma, V. Madhavan – Synthesis and Biological Evaluation of some New 2-(2-Methyl-5-Nitro-1H-Imidazol-1-yl)-N'-[(3Z)-2-Oxo-1,2-Dihydro-3H-Indol-3-ylidene]Acetohydrazide derivative, International Journal of ChemTech Research, Vol. 3, No. 2, pp. 772–777, April–June 2011, Co-Authored
• Judy Jays, Ankit Rochani, Amit Kumar, B.V. Suma, C.H.S. Venkataramana, V. Madhavan – In silico ADME and toxicity studies of some synthesized novel isatin derivatives, International Journal of Pharma and Bio Sciences, Vol. 2, No. 4, pp. 25–33, Oct–Dec 2011, Co-Authored
• Ankit K. Rochani, B.V. Suma, Surendra Kumar, Judy Jays, V. Madhavan – QSAR, ADME and QSTR studies of some synthesized anti-cancer 2-indolinone derivatives, International Journal of Pharma and Bio Sciences, Issue-4, Oct–Dec 2010, pp. 208–218, Co-Authored
• B.V. Suma, Ankit K. Rochani, C.H.S. Venkataramana, Judy Jays, V. Madhavan – Synthesis, Characterization, In vitro Antibacterial, Anti-inflammatory Evaluations of Novel 4-Quinolone containing Pyrazolidinedione derivatives, International Journal of ChemTech Research, Vol. 2, No. 4, pp. 2156–2162, Oct–Dec 2010

National Conference Papers

• Conference on Drug Design and Discovery Technologies (CDDT – 2019:Pretisha Cutinho C.H.S. Venkataramana Suma Venkatappa In Silico Hit Identification, Drug Repurposing, Pharmacokinetic and Toxicity Prediction of c-Met Kinase Inhibitors for Cancer Therapy, Conference on Drug Design and Discovery Technologies (CDDT – 2019) during Nov 21st-22nd November 2019 at Bengaluru, 54-59: Conference Proceedings
• Suma B V, Harish Kumar D Nuthan S, Anusha M, Kusuma S, Ranjith Reddy J P and HimaSusan, Evaluation studies of sodium and potassium ions in canned and fresh fruit juices by flame photometry,Life Science Edge,September 2019 Vol. 5 | Issue 1,58-64

National and International Conference Presentation

• Nayana R Jawale, Suma B V gave an oral presentation in the International Live Conference on Drug Discovery for Brain Health, Mental Well‑being, and Neurological Disorders (organized by OLCIAS), held in Turkey on March 29, 2025 at 8:00 PM IST: “Computational Exploration of Synbiotic‑Induced Gut‑Brain Modulation in Alzheimer’s Disease: A Network Pharmacology and Docking Study.”
• Chandana J K and Suma B V, with Nayana R Jawale, presented “Molecular Docking And Dynamics Studies Of Flavonoid Feistein As A Potential Fgfr1 Inhibitor In Renal Cancer” at the International Conference on Development of a Prospective Drug Molecule: From Initial Discovery to Marketed Product, organized by Sri Ram College of Pharmacy, Madhya Pradesh on April 9, 2025.
• Karthik Naidu, Suma B V, and Nayana R Jawale presented “Rational Design And Molecular Docking Of Coumarin‑Azetidione Hybrids: A Novel Class Of DNA Gyrase Inhibitors Against Tuberculosis” at the same conference in Madhya Pradesh on April 9, 2025.
• Karthik Naidu, Suma B V, and Nayana R Jawale presented an oral presentation titled “In Silico Exploration of Neohesperidin: A Promising AKT Inhibitor for Targeted Renal Cancer Therapy” at the International Conference on Advances in Pharmaceutical Science and Research to Novel Approaches (organized by Dattakala Shikshan Sanstha’s Institute of Pharmaceutical Science and Research, Pune, Maharashtra) held on January 24–25, 2025.
• Ramya Sri and Suma B V presented “Drug Repurposing Approach: Molecular Docking Analysis of Apalutamide Against Triple‑Negative Breast Cancer Target” at the same Pune conference on January 24–25, 2025.
• Anjali S Bhavikatti and Suma B V presented “In Silico Investigation of Luteolin’s Interaction with PI3K in Renal Cancer” at the Pune conference on January 24–25, 2025.
• Chayanika Talukdar and Suma B V presented “Exploring the Anticancer Potential of Rhamnetin: A Molecular Docking Study on Renal Cancer Targets” at the same Pune conference on January 24–25, 2025.
• Naga Anusha T A, Suma B V, and Nayana R Jawale presented “In Silico Investigation of Daidzein’s Interaction with PI3K in Renal Cancer” at the Pune conference on January 24–25, 2025.
• Brunda M A and Suma B V presented “Hesperidin as a Potential COX‑2/PGE2 Pathway Inhibitor: A Molecular Docking and ADMET Approach for Renal Cancer Therapy” at the same Pune conference on January 24–25, 2025.
• Apeksha K Hegde and Suma B V presented “Exploring Tetrahydro Pyrimidines For Tuberculosis Treatment: Molecular Docking And ADMET Insights” at SPER 14th Annual International Conference & Exhibition (SPER 2025), NITTE NGSM Institute of Pharmaceutical Sciences, Mangalore, Karnataka, India, January 24–25, 2025.
• Karthik Naidu, Suma B V, and Nayana R Jawale presented “Novel Coumarin‑Azetidone Hybrids As PI5P4K2Α Inhibitors: Design And Docking Studies For Breast Cancer Therapy” at SPER 2025 in Mangalore on January 24–25, 2025.
• J. K. Chandana, Suma B V, and Nayana R Jawale presented “Novel Coumarin‑Azetidione Hybrids as F‑ATP Synthase Inhibitors: Design and Docking Studies for Antitubercular Activity” at SPER 2025 in Mangalore on January 24–25, 2025.
• Nayana R Jawale and Suma B V presented “Designing of Novel Coumarin‑Azetidinone Hybrids for Targeting BACE‑1 in Alzheimer's Disease: An In‑silico Approach” at SPER 2025 in Mangalore on January 24–25, 2025.
• Karthik Naidu and Suma B V presented “Novel Coumarin‑Azetidone Hybrids as 14α‑Demethylase Inhibitors: Design and Docking Studies for Antifungal Activity” at DSU PHARMACON 2024—Emerging Tools and Techniques, College of Pharmaceutical Sciences, DSU Bengaluru on December 19–20, 2024.
• Chandana J K and Suma B V presented “Novel Coumarin‑Azetidone Hybrids As PBP Inhibitors: Design And Docking Studies For Antibacterial Activity” at the same DSU PHARMACON 2024 conference in Bengaluru on December 19–20, 2024.
• Apeksha K Hegde and Suma B V presented “Novel Tetrahydropyrimidine Derivative as an Inhibitor of Protein Tyrosine Phosphatase 1B: Molecular Docking Analysis and ADMET Studies” at the International Online Conference on Drug Discovery, Development, and Lead Optimisation (organized by School of Pharmacy and Emerging Sciences, Baddi University of Emerging Sciences & Technology, Himachal Pradesh) on April 5–6, 2024.
• Nayana J and B V Suma presented “Design and Synthesis of Novel 2‑Mercapto Benzimidazole Derivatives for the Treatment of Tuberculosis: An In‑silico and Experimental Approach” at the same online conference on April 5–6, 2024.
• Apeksha K Hegde and Suma B V presented “Novel Tetrahydropyrimidine Derivatives as Inhibitors of Topoisomerase II: Molecular Docking Analysis and ADMET Studies” at the International Conference on Explore Cutting‑edge Research & Innovation in Pharmaceutical, Life Sciences and Technology, Career Point University, Kota, Rajasthan on March 16, 2024.
• Shreya Shet and Suma B V presented “Discovery of Novel 7‑Hydroxy‑4‑Methyl‑Coumarin‑Based Antibacterials: A Computational Approach” at the Career Point University conference in Kota, Rajasthan on March 16, 2024.
• Apeksha K Hegde and Suma B V presented “The Novel Tetrahydropyrimidine Derivative as Inhibitor of Bcl‑2: Molecular Docking Analysis and ADMET Studies” at BBC‑Cure Symposium, Department of Biotechnology, FLAHS, M.S. Ramaiah University of Applied Sciences on November 28, 2023 (Poster Presentation).
• Shreya Shet and Suma B V presented “Discovery of Novel and Safer DNA Topoisomerase II Inhibitors as Anticancer Agents Using Computational Approach” at BBC‑Cure Symposium on November 28, 2023 (Poster Presentation).
• A. N. Sneha, Suma B V, and Brunda S N presented “Drug Repurposing on Fatal Familial Insomnia” at the Convention on Drug Discovery and Development, Dayananda Sagar University, Bangalore on October 17–18, 2023 (Poster Presentation).
• Y. A. Srija, Suma B V, and Brunda S N presented “Drug Repurposing on Emerging Liver Cirrhosis” at the same Dayananda Sagar University convention on October 17–18, 2023 (Poster Presentation).
• Janani N, Suma B V, and Brunda S N presented “Drug Repurposing on Emerging Multiple Myeloma” at the Dayananda Sagar University convention on October 17–18, 2023 (Poster Presentation).
• Vivan Ranjan Paitpal, Suma B V, and Brunda S N presented “Drug Repurposing on Emerging Nystagmus” at the Dayananda Sagar University convention on October 17–18, 2023 (Poster Presentation).
• Sai Baalaajee, Suma B V, and Brunda S N presented “Drug Repurposing on Thyroid Eye Disease” at the Dayananda Sagar University convention on October 17–18, 2023 (Poster Presentation).
• G Swathi Reddy, Suma B V, and Brunda S N presented “Drug Repurposing on Epilepsy” at the Dayananda Sagar University convention on October 17–18, 2023 (Poster Presentation).
• Apeksha K Hegde and Suma B V presented “Computational Analysis of EGFR Target for Treating Paronychia: Unveiling Molecular Insights” at the Dayananda Sagar University convention on October 17–18, 2023 (Poster Presentation).
• Shreya Shet and Suma B V presented “Discovery of Streptococcus mutans Glucosyltransferase-B (GTFB) Inhibitors Using Computational Approaches” at the Dayananda Sagar University convention on October 17–18, 2023 (Poster Presentation).
• B V Suma and Nayana J presented “Identification of Novel 2‑Mercaptobenzimidazole Derivatives for the Treatment of Breast Cancer: A Computational Approach” at the International Conference on Latest Trends and Innovations in Pharmaceutical and Biosciences, Career Point School of Pharmacy, Kota, Rajasthan on March 18, 2023 (Oral Presentation).
• Nayana J and B V Suma presented “Design of Novel 2‑Mercaptobenzimidazole Derivatives for the Treatment of Prostate Cancer: An In‑silico Approach” at the same conference in Kota, Rajasthan on March 18, 2023 (Oral Presentation).
• Brundha S N and B V Suma presented “In Silico Study on 1,3,4‑Thiadiazole Derivatives Tethered with Isoniazid on HER2 for Anti‑Breast Cancer Activity” at the same conference in Kota on March 18, 2023.
• Koushal V Gowda, Brundha S N, and Suma B V presented “Evaluation of Quinazoline Derivatives on Breast Cancer by In‑Silico Method” at the International Conference on Innovation and Advances in Pharmaceutical Sciences, ACU Karnataka, India on February 10–11, 2023 (Oral Presentation).
• Nayana J and Suma B V presented “Identification of Novel 2‑Mercaptobenzimidazole Derivatives for the Treatment of Tuberculosis: A Computational Approach” at the same ACU conference on February 10–11, 2023 (Oral Presentation).
• Akshith R, Brundha S N, and Suma B V presented “In‑Silico Evaluation Studies on Quinazoline Analogues as an Antifungal Agent” at the same ACU conference on February 10–11, 2023 (Oral Presentation).
• Anjana Vidya Srivathsa and Suma B V presented a poster on “Anti‑Cancer Activity of 1,3,4‑Thiadiazole Derivatives Based on Molecular Docking and ADMET Studies” at the New Horizons for Drug Discovery and Innovation in Health Care and Pharmaceutical Research, Dayananda College of Pharmaceutical Sciences on November 29, 2022.
• Apeksha K Hegde and Suma B V presented a poster on “Anti‑Tubercular Activity of 1,3,4‑Thiadiazole Derivatives Using In‑Silico Method” at the same Dayananda College event on November 29, 2022.
• Devika Muraleedharan and Suma B V presented a poster on “Molecular Docking and ADMET Studies of Thiadiazole Derivatives for Antibacterial Activity” at the November 29, 2022 event.
• Nandini M S and Suma B V presented a poster on “Anti‑Bacterial Activity of 1,3,4‑Thiadiazole Derivatives Using In‑Silico Method” at the November 29, 2022 event.
• Protyusha Maji and Suma B V presented a poster on “Molecular Docking and ADMET Studies of Thiadiazole Derivatives for Antifungal Activity” at the November 29, 2022 event.
• Shreya Shet and Suma B V presented a poster on “Molecular Docking and ADMET Studies of Pyrimidine Derivatives for Anti‑Inflammatory Activity” at the November 29, 2022 event.
• Tanya Maheshwari and Suma B V presented a poster on “Molecular Docking and ADMET Studies of Thiadiazole Derivatives for Anti‑Inflammatory Activity” at the November 29, 2022 event.
• Brundha S N and B V Suma presented “In Silico Study on 1,3,4‑Thiadiazole Derivatives with Isoniazid for Anti‑Tuberculosis Activity” at the 4th International Conference on To Foster the Drug Development Strategies in Novel Pharmaceutical and Its Global Challenges, December 16–17, 2022, Bangalore, India (Oral Presentation).
• Nayana Ravindra Jawale and Suma B V with Parasuraman P presented “Identification of Novel GABA‑A Inhibitor for the Treatment of Epilepsy: A Computational Approach” at the National Conference on Drug Discovery and In‑silico Drug Design, November 18, 2022, Royal School of Pharmacy, Assam Royal Global University, Guwahati (Oral Presentation).
• Brundha S N, Mahesh A R, Suma B V, and Parasuraman P presented “Evaluation of Potential Histamine H2 Receptor Antagonists: A Computational Approach” at the same conference on November 18, 2022.
• Suma B V and Medicharla Sri Satya presented “Molecular Docking and ADMET Studies of 2‑(1H‑Benzotriazoly‑1‑yl)Acetohydrazide Containing Isatin Derivatives for Breast Cancer” at the 5th Global Cancer Summit, Bengaluru, May 22, 2022 (oral presentation).
• Aiswariya and Suma B V presented “Molecular Docking and ADMET Studies of Benzotriazole Derivatives Tethered with Isoniazid” at the 5th Global Cancer Summit in Bengaluru on May 22, 2022 (oral presentation).
• Medicharla Sri Satya and Suma B V presented “Molecular Docking and ADMET Studies of Benzimidazole Derivatives Tethered with Isoniazid for Anti‑Cancer Property” at the same summit on May 22, 2022 (oral presentation).
• Jhansi Laxmi C H and Suma B V presented “Molecular Docking and ADMET Studies of Stigmasterol for Anti‑Microbial Properties” at the same summit on May 22, 2022 (oral presentation).
• Shraddha Prabhakar Hegde and Suma B V presented “Molecular Docking and ADMET Studies of Cholesta‑22,24‑dien‑5‑ol,4,4‑dimethyl Compound for Antibacterial Property” at the same summit on May 22, 2022 (oral presentation).
• Medicharla Sri Satya and Suma B V presented “Molecular Docking and ADMET Studies of Benzimidazole Derivatives Tethered with Isoniazid for Breast Cancer” at the 1st National Conference on Clinical Pharmacology, DST‑SERB, Government of India, April 29, 2022 (oral presentation).
• Aiswariya and Suma B V presented “Molecular Docking and ADMET Studies of Benzotriazole Derivatives Tethered with Isoniazid” at the same conference on April 29, 2022.
• Medicharla Sri Satya and Suma B V presented “Molecular Docking and ADMET Studies of Ethanone 1‑(2‑Hydroxy‑5‑Methylphenyl) for Anti‑Microbial Properties” at the International Conference of Contemporary Antimicrobial Research, December 9–10, 2021.
• Aiswariya and Suma B V presented “Molecular Docking and ADMET Studies of 2,5‑Dihydroxy‑4‑Isopropyl‑2,4,6‑Cycloheptatriene‑1‑One for Antibacterial Properties” at the same December 9–10, 2021 conference.
• Tharun Bharadwaj L, B V Suma, and Harish Kumar D R presented “In‑Silico Drug Design of Benzothiazole Tethered with Isoniazid as Anticancer Agent Against Various Targets” at Society of Xenobiotics 2021, July 14–17, 2021 (oral presentation).
• Burhanuddin Madriwala, Suma B V, and Harish Kumar D R presented “Molecular Docking Study of Hentriacontane for Anticancer & Antitubercular Activity” at the same Society of Xenobiotics conference on July 14–17, 2021 (oral presentation).
• Sushma M, B V Suma, M Narayana Babu, and C H S Venkataramana presented “Comparative Evaluation of Pharmacological Activity of Novel Benzothiazole‑Azetidinone Hybrid Compounds by Molecular Docking Studies” at a National Conference on Recent Advancements in Pharmaceutical Science, January 18–22, 2021 (oral presentation).
• Tharun L Bharadwaj, B V Suma, and C H S Venkataramana presented “In Silico Drug Design of Benzothiazole Tethered with Isoniazid as Antibacterial Agent Against Shikimate Kinase” at the same January 18–22, 2021 conference (oral presentation).
• International Scopus‑Indexed Conference “Innovating the Pharmaverse: New Vistas and Avenues in Pharmaceutical and Clinical Domain” on November 8–9, 2019 at Krupanidhi College of Pharmacy, Bangalore. Presentations included UV‑Spectrophotometric Method for Estimation of Ticagrelor in Bulk and Tablets, and Complexometric Estimation of Calcium Content from Milk Samples.
• Pretisha Cutinho, C H S Venkataramana, and Suma Venkatappa presented at the Conference on Drug Design and Discovery Technologies (CDDT – 2019), November 21–22, 2019, Bengaluru.
• BioRujivith 2019, International Conference on Biotechnological Advances in Medicinal Plants and Natural Products, September 19–20, 2019 at Garden City University, Bangalore — evaluation of sodium and potassium ions in canned and fresh fruit juices (oral presentation).
• First Pharmaceutical Sciences Congress, March 18–19, 2017 at M S Ramaiah University of Applied Sciences, Bangalore: Quantitative Structure‑Toxicity Relationship studies of novel Isatin derivatives containing Benzotriazole moiety (poster presentation).
• World Congress on Drug Discovery and Development, November 23–25, 2016 at IISc, Bangalore: Synthesis and biological activity of novel benzothiazole derivatives (poster presentation).
• 67th Indian Pharmaceutical Congress, December 19–21, 2015, Mysore: In vitro anti‑inflammatory activity of synthesized benzothiazole derivatives (poster presentation).
• 66th Indian Pharmaceutical Congress, December 23–25, 2015, HITEX, Hyderabad: multiple poster presentations on synthesis, toxicity and activity studies of benzothiazole derivatives.
• 63rd Indian Pharmaceutical Congress, December 16–18, 2011, Bengaluru: High‑performance thin‑layer chromatographic estimation of atorvastatin calcium and aspirin in capsules (poster presentation).
• 61st Indian Pharmaceutical Congress, December 11–13, 2009, Ahmedabad: Software programmes: Neophyte of new drug discovery in India (poster presentation).
• 57th Indian Pharmaceutical Congress, December 4–6, 2005, Hyderabad: Spectrophotometric method for Norfloxacin estimation (poster presentation).

• Karnataka State Pharmacy Council (Reg # 42998) http://www.kspcdic.com/
• Association of Pharmacy Teachers of India (#KA/LM-430) http://www.aptiindia.org/

• B. V. Suma Vijayalakshmi “Thiadiazole Derivatives with Pyrazolidinedione Moiety as Potential Anti-Inflammatory and Anti-Convulsant Agents” Indian Patent Application: 5049/CHE/2014, October 08, 2014.